Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper.
No Thumbnail Available
Identifiers
Date
2020-01-03
Authors
Hox, Valerie
Lourijsen, Evelijn
Jordens, Arnout
Aasbjerg, Kristian
Agache, Ioana
Alobid, Isam
Bachert, Claus
Boussery, Koen
Campo, Paloma
Fokkens, Wytske
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Because of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that-potentially severe-side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Glucocorticosteroids, Rhinitis, Rhinosinusitis